Paper Details
- Home
- Paper Details
Original Abstract of the Article :
During the Coronavirus Disease 2019 (COVID-19) pandemic, skin lesions resembling those seen in pernio (chilblains) have been observed in patients with COVID-19 infection. The term "COVID toes" has been used when there is toe involvement. We describe the case of a fully vaccinated, 56-year-old woman ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691508/
データ提供:米国国立医学図書館(NLM)
Cilostazol: A Potential Treatment for COVID Toes
This research presents a case report exploring the potential of cilostazol, a vasodilator, as a treatment for COVID toes, a pernio-like skin condition associated with COVID-19 infection. The study focuses on a single patient who developed COVID toes and experienced resolution of the lesions after treatment with cilostazol.
Cilostazol Shows Promise in Addressing COVID Toes
The case report suggests that cilostazol may be a potential therapeutic option for COVID toes. While further research is needed to confirm this finding, the positive response observed in this case provides a promising starting point for exploring cilostazol as a treatment modality.
Navigating the Uncharted Terrain of COVID-19
Imagine a camel caravan venturing through a previously unexplored desert. Along the way, they encounter unexpected challenges, requiring innovative solutions. Similarly, the COVID-19 pandemic has presented numerous medical challenges, and research like this helps us navigate uncharted terrain and find solutions for emerging conditions like COVID toes.
Dr. Camel's Conclusion
This case report provides a glimpse into the potential of cilostazol as a treatment for COVID toes. While further research is needed to confirm its efficacy and safety, this case offers a promising starting point for exploring cilostazol as a potential therapeutic option. It exemplifies our continued efforts to understand and address the complexities of COVID-19.
Date :
- Date Completed 2023-03-21
- Date Revised 2023-03-23
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.